in Newswire Published on September 25, 2020

‘Wasteful’: Class Action Claims Genentech Reaped Millions by Selling Cancer, Asthma Drugs in Excessive Dosage Amounts

Williamson et al. v. Genentech, Inc. et al.

Filed: September 24, 2020 § 3:20-cv-06695

A class action claims Genentech has sold medications in single-use vials that contain more medicine than is appropriate for most patients, causing excessive waste.

Case Spotlight

Camp Lejeune

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on September 25, 2020 — 4:56 PM

Erin Shaak

erin@classaction.org

Erin works primarily on ClassAction.org’s newswire, reporting on cases as they happen.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.